PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 30964170-11 2019 ATG5 could directly bind to miRNA-153-3p, and ATG5 was highly expressed in gefitinib-resistant NSCLC. Gefitinib 75-84 autophagy related 5 Homo sapiens 0-4 30964170-0 2019 MiRNA-153-3p promotes gefitinib-sensitivity in non-small cell lung cancer by inhibiting ATG5 expression and autophagy. Gefitinib 22-31 autophagy related 5 Homo sapiens 88-92 30964170-2 2019 PATIENTS AND METHODS: The expressions of miRNA-153-3p, LC3B and ATG5 in gefitinib-resistant and gefitinib-sensitive NSCLC tissues were determined by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). Gefitinib 72-81 autophagy related 5 Homo sapiens 64-68 30964170-6 2019 The regulatory effects of miRNA-153-3p/ATG5 on gefitinib-sensitivity and apoptosis were finally examined by cytotoxicity assay and Annexin V-fluorescein isothiocyanate (FITC)/Propidium Iodide (PI) staining, respectively. Gefitinib 47-56 autophagy related 5 Homo sapiens 39-43 30964170-11 2019 ATG5 could directly bind to miRNA-153-3p, and ATG5 was highly expressed in gefitinib-resistant NSCLC. Gefitinib 75-84 autophagy related 5 Homo sapiens 46-50 30964170-12 2019 The correlation analysis found a negative correlation between ATG5 and miRNA-153-3p and a positive correlation between ATG5 and LC3B in gefitinib-resistant NSCLC. Gefitinib 136-145 autophagy related 5 Homo sapiens 119-123 30964170-13 2019 More importantly, ATG5 reversed the regulatory effects of miRNA-153-3p on autophagy, gefitinib-sensitivity and apoptosis of PC-9/GR and HCC827/GR cells. Gefitinib 85-94 autophagy related 5 Homo sapiens 18-22 30964170-15 2019 The overexpression of miRNA-153-3p enhances gefitinib-sensitivity in NSCLC by inhibiting autophagy via downregulating ATG5. Gefitinib 44-53 autophagy related 5 Homo sapiens 118-122 29259263-6 2017 We also found that ATG5 rs510432, ATG5 rs688810, ATG10 rs10036653 and ATG10 rs1864182 were associated with primary or acquired resistance to gefitinib. Gefitinib 141-150 autophagy related 5 Homo sapiens 19-23 29717538-5 2018 Western blotting indicated that gefitinib combined with CUR, DMC, or BDMC led to decrease Bcl-2 protein expression which is an antiapoptotic protein and to increase ATG5, Beclin 1, p62/SQSTM1, and LC3 expression that associated with cell autophagy in SAS cells. Gefitinib 32-41 autophagy related 5 Homo sapiens 165-169 29259263-6 2017 We also found that ATG5 rs510432, ATG5 rs688810, ATG10 rs10036653 and ATG10 rs1864182 were associated with primary or acquired resistance to gefitinib. Gefitinib 141-150 autophagy related 5 Homo sapiens 34-38 28399862-5 2017 METHODS: We designed chitosan nanoparticles (NPs) to promote the co-delivery of gefitinib (an anti-cancer drug) and shRNA-expressing plasmid DNA that targets the Atg-5 gene (shAtg-5) as an autophagy inhibitor to improve anti-cancer effects and autophagy mediation. Gefitinib 80-89 autophagy related 5 Homo sapiens 162-167 24965408-13 2014 Compound C AMPK inhibitor could reverse the activation of gefitinib on autophagy, as determined by Beclin 1, Atg5 and Atg7 mRNA levels. Gefitinib 58-67 autophagy related 5 Homo sapiens 109-113 21655094-6 2011 Moreover, cytotoxicity induced by gefitinib or erlotinib was greatly enhanced after autophagy inhibition by the pharmacological inhibitor chloroquine (CQ) and siRNAs targeting ATG5 and ATG7, the most important components for the formation of autophagosome. Gefitinib 34-43 autophagy related 5 Homo sapiens 176-180